LpD64
Overweight and /or obesity
• Modulation of intestinal microbiota
• Clinical Phase I/II positive
Pipeline
4 products in clinical development
VAL-070
Mild to moderate hypercholesterolemia
• Reduction of blood LDL-cholesterol
• Clinical Phase I/II positive